This brand name is authorized in Nigeria.
The drug CELOXIGEN contains one active pharmaceutical ingredient (API):
1
|
UNII
JCX84Q7J1L - CELECOXIB
|
|
Celecoxib is an oral, selective, cyclooxygenase-2 (COX-2) inhibitor within the clinical dose range (200-400 mg daily). No statistically significant inhibition of COX-1 (assessed as ex vivo inhibition of thromboxane B2 [TxB2] formation) was observed in this dose range in healthy volunteers. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-100581 | Capsule | CELOXIGEN -100 CAPSULES CAP 100 mg 1 X 10 | 75 NF-PP-344331 CELOXIGEN -100 CAPSULES CELECOXIB 100 MG CELOXIGEN BP 100 MG EXCIPIENTS: Lactose Monohydrate, Sodium Lauryl Sulfate, Crospovidone Type-B, Hydroxy Propyl Cellulose, Sodium Stearyl Fumarate A4-100581 Drugs Imported Products 110 POM 2 7/24/2023 GENEITH PHARMACEUTICALS LIMITED, ADEWALE CRESCENT, OFF EWENLA STREET, OSHODI ISOLO LAGOS 8122912281 ngouzoamaka@yahoo.com NOVAGEN HEALTHCARE PVT. LTD, PLOT NO. 102-111, HORIZON IND. PARK, N.H. NO.48 AT: BAMANGAM, DIST-VADODARA-391 243 GUJARAT STATE, INDIA., India | 31/10/2023 |
| A4-100582 | Capsule | CELOXIGEN-200 CAPSULES CAP 200 mg 1 X 10 | 76 NF-PP-344338 CELOXIGEN-200 CAPSULES CELECOXIB 200MG Each capsule contains: CELECOXIB BP 200MG EXCIPIENTS: Lactose Monohydrate, Sodium Lauryl Sulfate, Crospovidone Type-B, Hydroxy Propyl Cellulose, Sodium Stearyl Fumarate A4-100582 Drugs Imported Products 110 POM 2 7/24/2023 GENEITH PHARMACEUTICALS LIMITED, ADEWALE CRESCENT, OFF EWENLA STREET, OSHODI ISOLO LAGOS 8122912281 ngouzoamaka@yahoo.com NOVAGEN HEALTHCARE PVT. LTD, PLOT NO. 102-111, HORIZON IND. PARK, N.H. NO.48 AT: BAMANGAM, DIST-VADODARA-391 243 GUJARAT STATE, INDIA., India | 31/10/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M01AH01 | Celecoxib | M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AH Coxibs |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-100581, A4-100582 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.